Bank of America
VNRX icon

Bank of America’s VolitionRx Ltd VNRX Stock Holding History

Bank of America’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48
Closed -$245 – 6889
2025
Q4 		$245 Hold
48
– – ﹤0.01% 6668
2025
Q3 		$650 Buy
48
+2
+4% +$27 ﹤0.01% 7544
2025
Q2 		$692 Buy
46
+15
+48% +$165 ﹤0.01% 7600
2025
Q1 		$353 Buy
31
+2
+7% +$24 ﹤0.01% 7582
2024
Q4 		$353 Hold
29
– – ﹤0.01% 7468
2024
Q3 		$353 Buy
29
+3
+12% +$39 ﹤0.01% 7450
2024
Q2 		$318 Buy
+26
New +$381 ﹤0.01% 7452
2023
Q4 		– Sell
-50
Closed -$689 – 8245
2023
Q3 		$689 Hold
50
– – ﹤0.01% 7284
2023
Q2 		$1.39K Sell
50
-3,000
-98% -$98.7K ﹤0.01% 7198
2023
Q1 		$117K Buy
3,050
+2,653
+668% +$111K ﹤0.01% 6195
2022
Q4 		$19.3K Sell
397
-16
-4% -$621 ﹤0.01% 6751
2022
Q3 		$11K Buy
413
+30
+8% +$1.14K ﹤0.01% 7211
2022
Q2 		$16K Buy
383
+180
+89% +$9.07K ﹤0.01% 7256
2022
Q1 		$12K Buy
203
+126
+164% +$7.14K ﹤0.01% 7684
2021
Q4 		$5K Sell
77
-53
-41% -$3.62K ﹤0.01% 7839
2021
Q3 		$8K Sell
130
-643
-83% -$40.7K ﹤0.01% 7634
2021
Q2 		$51K Sell
773
-1,825
-70% -$123K ﹤0.01% 6826
2021
Q1 		$196K Buy
2,598
+1,634
+170% +$140K ﹤0.01% 6057
2020
Q4 		$75K Buy
964
+161
+20% +$11.1K ﹤0.01% 6131
2020
Q3 		$51K Sell
803
-402
-33% -$27.3K ﹤0.01% 6007
2020
Q2 		$94K Sell
1,205
-236
-16% -$17K ﹤0.01% 5704
2020
Q1 		$90K Buy
1,441
+1,141
+380% +$95.1K ﹤0.01% 5582
2019
Q4 		$28K Sell
300
-43
-13% -$4.46K ﹤0.01% 6428
2019
Q3 		$39K Buy
343
+40
+13% +$3.19K ﹤0.01% 6404
2019
Q2 		$19K Sell
303
-4
-1% -$259 ﹤0.01% 6584
2019
Q1 		$20K Buy
307
+7
+2% +$391 ﹤0.01% 6501
2018
Q4 		$11K Buy
300
+250
+500% +$11.9K ﹤0.01% 6620
2018
Q3 		$3K Buy
+50
New +$2.06K ﹤0.01% 6969
2018
Q2 		– Hold
0
– – – 7345
2016
Q3 		– Hold
0
– – – 7377
2016
Q2 		– Hold
0
– – – 7402

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Bank of America's VNRX Position: Q1 2026 in Review

Bank of America sold out of VolitionRx Ltd (VNRX) in Q1 2026, closing a stake of 48 shares — an estimated $245 sold.

Bank of America first reported a position in VNRX in Q3 2018 and held it in 28 quarters. The position peaked at $196K in Q1 2021. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Bank of America reported no remaining VolitionRx Ltd position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 48 VolitionRx Ltd shares in Q1 2026, an estimated $245.
  • Bank of America first reported a position in VolitionRx Ltd in Q3 2018 and held it in 28 quarters.
  • Bank of America's VolitionRx Ltd position peaked at $196K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.